Annual ROE
-221.45%
+1782.52%+88.95%
01 June 2024
Summary:
Kintara Therapeutics annual return on equity is currently -221.45%, with the most recent change of +1782.52% (+88.95%) on 01 June 2024. During the last 3 years, it has risen by +140.50% (+38.82%).KTRA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-444.39%
+391.91%+46.86%
01 June 2024
Summary:
Kintara Therapeutics quarterly return on equity is currently -444.39%, with the most recent change of +391.91% (+46.86%) on 01 June 2024. Over the past year, it has increased by +128.39% (+22.42%).KTRA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KTRA ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +89.0% | +22.4% |
| 3 y3 years | +38.8% | -184.8% |
| 5 y5 years | +45.9% | -88.8% |
KTRA ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -121.8% | -100.0% |
Kintara Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | -221.45%(-88.9%) | -444.39%(-46.9%) |
| Mar 2024 | - | -836.30%(-54.0%) |
| Dec 2023 | - | -1819.34%(+217.6%) |
| Sept 2023 | - | -572.78%(+102.7%) |
| June 2023 | -2003.97%(+943.1%) | -282.62%(+34.0%) |
| Mar 2023 | - | -210.84%(+4.6%) |
| Dec 2022 | - | -201.64%(+6.3%) |
| Sept 2022 | - | -189.67%(+13.9%) |
| June 2022 | -192.12%(-46.9%) | -166.48%(-7.5%) |
| Mar 2022 | - | -179.94%(+6.9%) |
| Dec 2021 | - | -168.27%(+7.9%) |
| Sept 2021 | - | -156.01%(-34.0%) |
| June 2021 | -361.95%(-89.6%) | -236.27%(-9.0%) |
| Mar 2021 | - | -259.64%(-11.0%) |
| Dec 2020 | - | -291.64%(-19.1%) |
| Sept 2020 | - | -360.29%(+62.7%) |
| June 2020 | -3469.96%(+748.3%) | -221.38%(+27.7%) |
| Mar 2020 | - | -173.37%(-10.2%) |
| Dec 2019 | - | -193.05%(-18.0%) |
| Sept 2019 | - | -235.39%(-29.3%) |
| June 2019 | -409.06%(+99.6%) | -333.03%(+39.4%) |
| Mar 2019 | - | -238.85%(+28.0%) |
| Dec 2018 | - | -186.58%(+19.2%) |
| Sept 2018 | - | -156.47%(+26.4%) |
| June 2018 | -204.93%(+66.8%) | -123.77%(+1.1%) |
| Mar 2018 | - | -122.37%(-8.8%) |
| Dec 2017 | - | -134.12%(-7.1%) |
| Sept 2017 | - | -144.40%(-35.3%) |
| June 2017 | -122.85% | -223.18%(-20.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | -280.04%(-7.5%) |
| Dec 2016 | - | -302.70%(-34.4%) |
| Sept 2016 | - | -461.56%(-50.9%) |
| June 2016 | -182.45%(-134.5%) | -939.73%(-178.5%) |
| Mar 2016 | - | 1197.34%(-99.9%) |
| Dec 2015 | - | 1.08 M%(<-9900.0%) |
| Sept 2015 | - | -944.66%(+63.1%) |
| June 2015 | 529.25%(-266.5%) | -579.13%(+82.4%) |
| Mar 2015 | - | -317.56%(-108.6%) |
| Dec 2014 | - | 3708.79%(+670.5%) |
| Sept 2014 | - | 481.35%(+250.5%) |
| June 2014 | -317.88%(-131.4%) | - |
| Mar 2014 | - | 137.33%(-55.1%) |
| Dec 2013 | 1013.53%(+339.7%) | 305.53%(+3.4%) |
| Sept 2013 | - | 295.58%(-49.3%) |
| June 2013 | - | 583.05%(-59.6%) |
| Mar 2013 | - | 1442.92%(+1258.2%) |
| Dec 2012 | - | 106.24%(-56.0%) |
| Sept 2012 | - | 241.51%(-59.4%) |
| June 2012 | - | 595.28%(-137.4%) |
| June 2012 | 230.49%(-174.5%) | - |
| Mar 2012 | - | -1593.55%(+384.7%) |
| Dec 2011 | - | -328.80%(+59.3%) |
| Sept 2011 | - | -206.38%(+3.1%) |
| June 2011 | -309.35%(+2324.4%) | -200.20%(+103.9%) |
| Mar 2011 | - | -98.19%(+37.0%) |
| Dec 2010 | - | -71.67%(+202.5%) |
| Sept 2010 | - | -23.69%(+316.3%) |
| June 2010 | -12.76% | -5.69% |
FAQ
- What is Kintara Therapeutics annual return on equity?
- What is the all time high annual ROE for Kintara Therapeutics?
- What is Kintara Therapeutics annual ROE year-on-year change?
- What is Kintara Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Kintara Therapeutics?
- What is Kintara Therapeutics quarterly ROE year-on-year change?
What is Kintara Therapeutics annual return on equity?
The current annual ROE of KTRA is -221.45%
What is the all time high annual ROE for Kintara Therapeutics?
Kintara Therapeutics all-time high annual return on equity is 1013.53%
What is Kintara Therapeutics annual ROE year-on-year change?
Over the past year, KTRA annual return on equity has changed by +1782.52% (+88.95%)
What is Kintara Therapeutics quarterly return on equity?
The current quarterly ROE of KTRA is -444.39%
What is the all time high quarterly ROE for Kintara Therapeutics?
Kintara Therapeutics all-time high quarterly return on equity is 1.08 M%
What is Kintara Therapeutics quarterly ROE year-on-year change?
Over the past year, KTRA quarterly return on equity has changed by +128.39% (+22.42%)